Atypical Ketoacidosis and Protracted Hyperglycosuria after Treatment with Ipragliflozin, an SGLT2 Inhibitor

We herein present the case of a 21-year-old diabetic obese woman who developed ketoacidosis following the administration of ipragliflozin, a sodium-glucose cotransporter 2 (SGLT2) inhibitor. At the time of admission, although her serum glucose level was only 175 mg/dL, laboratory tests showed ketoac...

Descripción completa

Detalles Bibliográficos
Autores principales: Miyauchi, Masaaki, Toyoda, Masao, Fukagawa, Masafumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5519469/
https://www.ncbi.nlm.nih.gov/pubmed/28674356
http://dx.doi.org/10.2169/internalmedicine.56.7945

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5519469/
https://www.ncbi.nlm.nih.gov/pubmed/28674356
http://dx.doi.org/10.2169/internalmedicine.56.7945

Ejemplares similares